Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Sepsis
NCT02319265Phase 2Withdrawn
- Sponsor
- University of Aberdeen
- Start
- Apr 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in sepsis, sponsored by University of Aberdeen. Planned start Apr 2017; status: withdrawn.
02
Drugs
melatonin
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT02319265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02319265.